1999, Taxus plantation
……
2001, company established
2007, GMP approved
2009, company name change to current
2011, sales volume more than RMB100million
2012, passed GMP re-inspection
2014, IPO, received production license of Letrozole,Gefitinib and Erlotinib
2015, received Docetaxel GMP, received BE license of Imatinib,Erlotinib(API and tablet), passed US-FDA GMP inspection.
2016, received Paclitaxel GMP, received BE license of Letrzole(API and tablet)
……
